Hoey Investments »

Iovance Biotherapeutics shares owned by Hoey Investments

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Hoey Investments from 13F filings

Historical chart of Hoey Investments investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Hoey Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Hoey Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3k 2.0k 2.17
2025-06-30 $3.4k 2.0k 1.72
2025-03-31 $6.7k 2.0k 3.33

More positions owned by Hoey Investments

Nvidia Corporation Call Call Option (Principal) (NVDA)
Amazon Call Call Option (Principal) (AMZN)
Meta Platforms Call Call Option (Principal) (META)
Microsoft Corporation (MSFT)
Palantir Technologies Call Call Option (Principal) (PLTR)
Apple (AAPL)
Broadcom Call Call Option (Principal) (AVGO)
Wells Fargo & Company (WFC)
Ge Aerospace Com New (GE)
JPMorgan Chase & Co. (JPM)
Goldman Sachs (GS)
Bank of America Corporation (BAC)
Morgan Stanley Com New (MS)
Uber Technologies (UBER)
Wal-Mart Stores (WMT)

View all positions for Hoey Investments

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics